The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.30% | -2.53% | 0.54% | -0.98% | 9.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.30% | -2.53% | 0.54% | -0.98% | 9.31% |
| Cost of Revenue | 3.98% | 4.81% | 0.39% | -1.13% | 6.28% |
| Gross Profit | -11.96% | -11.26% | 0.71% | -0.81% | 13.15% |
| SG&A Expenses | 21.61% | 22.58% | -22.28% | -23.45% | -15.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -412.00% | -414.51% | 1,180.13% | 1,160.82% | -97.57% |
| Total Operating Expenses | 6.46% | 7.31% | -2.27% | -3.75% | 1.90% |
| Operating Income | -33.56% | -33.03% | 10.67% | 9.00% | 41.12% |
| Income Before Tax | -19.61% | -18.97% | 14.14% | 12.42% | 44.48% |
| Income Tax Expenses | -29.87% | -29.31% | 21.20% | 19.36% | 35.95% |
| Earnings from Continuing Operations | -17.33% | -16.67% | 12.34% | 10.64% | 46.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 495.93% | 498.84% | 54.10% | 52.41% | 244.00% |
| Net Income | -17.24% | -16.57% | 12.35% | 10.65% | 46.54% |
| EBIT | -33.56% | -33.03% | 10.67% | 9.00% | 41.12% |
| EBITDA | -26.97% | -26.39% | 8.35% | 6.71% | 34.17% |
| EPS Basic | -17.22% | -16.54% | 12.50% | 10.64% | 46.74% |
| Normalized Basic EPS | -22.94% | -22.50% | 16.79% | 14.91% | 35.47% |
| EPS Diluted | -17.22% | -16.54% | 12.50% | 10.64% | 46.74% |
| Normalized Diluted EPS | -22.94% | -22.50% | 16.79% | 14.91% | 35.47% |
| Average Basic Shares Outstanding | -0.02% | -0.02% | 0.00% | 0.00% | -0.01% |
| Average Diluted Shares Outstanding | -0.02% | -0.02% | 0.00% | 0.00% | -0.01% |
| Dividend Per Share | 0.52% | 1.55% | 27.91% | 26.14% | 95.96% |
| Payout Ratio | 1.05% | 1.05% | -- | -- | 0.34% |